Effect of the levonorgestrel-releasing intrauterine system on uterine myomas in a renal transplant patient
Case report
OA: closed
CC0
⤵ 11 in-corpus citations
AI-generated summary
A levonorgestrel-releasing intrauterine system effectively treated menorrhagia, dysmenorrhea, and reduced uterine and myoma size in a renal transplant patient with uterine myomas.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
The levonorgestrel-releasing intrauterine system (LNG-IUS) has been used in the treatment of both idiopathic menorrhagia and adenomyosis. An electronic search of the on-line medical literature revealed no reports of its use for menorrhagia secondary to uterine myomas. Presented here is the successful treatment of uterine myomas with menorrhagia in a woman with a renal transplant. There was a significant reduction in menorrhagia, dysmenorrhea, and uterine and myoma size with the use of the LNG-IUS. We believe that this system provides an alternative to conventional hysterectomy and gonadotrophin-releasing hormonal analog medical treatment for uterine myomas, with a possibly inhibitory effect on myoma growth.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (12)
- A comparison of flurbiprofen, tranexamic acid, and a levonorgestrel-releasing intrauterine contraceptive device in the treatment of idiopathic menorrhagia via openalex
- mRNA expression of insulin-like growth factor-I (IGF-I) is suppressed and those of IGF-II and IGF-binding protein-1 are constantly expressed in the endometrium during use of an intrauterine levonorgestrel system via openalex
- Treatment of adenomyosis-associated menorrhagia with a levonorgestrel-releasing intrauterine device via openalex
- W2070761958 via openalex
- W2119767373 via openalex
- W2273333468 via openalex
- W2293013867 via openalex
- W4231243180 via openalex
- W1997430923 via openalex
- W4242280866 via openalex
- W2014994159 via openalex
- W2060059789 via openalex
Cited by (9)
- Surgical Management Options for Patients with Infertility and Endometriosis 2010
- Contraception and gynaecological care 2009
- Efeitos do sistema intra-uterino de Levonorgestrel sobre marcadores de risco cardiovascular de pacientes com endometriose: estudo comparativo com o análogo do GnRH 2009
- Levonorgestrelį išskiriančios gimdos spiralės vartojimas ginekologijoje 2009
- Intrauterine progestins, progesterone antagonists, and receptor modulators: a review of gynecologic applications 2009
- Non-contraceptive uses of levonorgestrel-releasing hormone system (LNG-IUS)--a systematic enquiry and overview 2005
- Hysteroscopic endometrial ablation as a treatment for abnormal uterine bleeding in patients with renal transplants 2004
- Levonorgestrel-releasing intrauterine system in the treatment of heavy menstrual bleeding 2004
- Efficacy of the levonorgestrel intrauterine system in treating menorrhagia: actualities and ambiguities 2002
Source provenance
- europepmc
- last seen: 2026-10-16T06:09:50.462052+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-10-08T20:59:07.345995+00:00
- unpaywall
- last seen: 2026-10-16T06:24:35.758740+00:00
License: CC0
· commercial use OK